BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12082609)

  • 1. p14(ARF) regulates E2F activity.
    Mason SL; Loughran O; La Thangue NB
    Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ; Dong YB; Yang H; McMasters KM
    Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO; Samuel T; Rauch P; Funk JO
    Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
    EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
    Dilla T; Romero J; Sanstisteban P; Velasco JA
    Oncogene; 2002 Apr; 21(15):2376-86. PubMed ID: 11948421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
    Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors.
    Parisi T; Pollice A; Di Cristofano A; Calabrò V; La Mantia G
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1138-45. PubMed ID: 11883935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.
    Chen G; Ghosh P; O'Farrell T; Munk R; Rezanka LJ; Sasaki CY; Longo DL
    J Biol Chem; 2012 Jun; 287(27):23184-95. PubMed ID: 22621932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.
    Sánchez-Aguilera A; Sánchez-Beato M; García JF; Prieto I; Pollan M; Piris MA
    Blood; 2002 Feb; 99(4):1411-8. PubMed ID: 11830494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner.
    Li Y; He L; Bruce A; Parihar K; Ingram A; Liu L; Tang D
    Biochim Biophys Acta; 2006 Aug; 1763(8):787-96. PubMed ID: 16764954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
    Dimri GP; Itahana K; Acosta M; Campisi J
    Mol Cell Biol; 2000 Jan; 20(1):273-85. PubMed ID: 10594030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arf induces p53-dependent and -independent antiproliferative genes.
    Kuo ML; Duncavage EJ; Mathew R; den Besten W; Pei D; Naeve D; Yamamoto T; Cheng C; Sherr CJ; Roussel MF
    Cancer Res; 2003 Mar; 63(5):1046-53. PubMed ID: 12615721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
    Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
    Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.